Skip to content

Research at St Andrews

3-fluoro-GABA enantiomers: exploring the conformation of GABA binding to GABA(A) receptors and GABA aminotransferase

Research output: Contribution to journalReview article



The neurotransmitter GABA is the main inhibitory neurotransmitter of the CNS. It is estimated that 20-50% of all neuronal synapses are GABAergic. Distinct types of GABA receptor have been identified (GABA(A), GABA(B) and GABA(AOr) [GABA(C)]). The GABA(A) and GABA(AOr) variant found in the retina receptors (informally termed GABA(C)) are physiologically related in that they are both ligand (GABA)-gated chloride ion channels. The GABA(B) receptor mediates its response by modulating Ca2+ and K+ ion channels, which then trigger coupled G-proteins. These receptors have not succumbed to x-ray structural analysis at a suitable resolution to determine the nature of GABA binding. However, knowledge of how GABA binds is important for the design of novel agonists and antagonists, and the development of neuropharmaceutical agents. Comparison of the relative agonistic efficacy of the (R)- and (S)-enantiomers of 3-fluoro-GABA has been used as a method to probe the binding conformation of the neurotransmitter binding to target proteins. The analysis relies on the stereoelectronic influence of the C F bond interacting with the ammonium group of GABA, an electrostatic interaction that favors solution conformers where the substituents come close (gauche rather than anti). This article describes how comparative analysis of these enantiomers has been used to assess the conformation of GABA binding to GABA(A) and the GABA-metabolizing enzyme, GABA transaminase.



Original languageEnglish
Pages (from-to)189-195
Number of pages7
JournalFuture Medicinal Chemistry
Issue number2
Publication statusPublished - Feb 2011

    Research areas


Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. An enzymatic Finkelstein reaction: fluorinase catalyses direct halogen exchange

    Lowe, P. T., Cobb, S. L. & O'Hagan, D., 28 Aug 2019, In : Organic & Biomolecular Chemistry. 17, 32, p. 7493-7496 4 p.

    Research output: Contribution to journalArticle

  2. Fluorine-containing substituents: metabolism of the α,α-difluoroethyl thioether motif

    Rodil, A., Slawin, A. M. Z., Al-Maharik, N., Tomita, R. & O’Hagan, D., 28 Jun 2019, In : Beilstein Journal of Organic Chemistry. 15, p. 1441-1447 7 p.

    Research output: Contribution to journalArticle

  3. Fluorine in pheromones: synthesis of fluorinated 12-dodecanolides as emerald ash borer pheromone mimetics

    Zhang, Q., Teschers, C. S., Callejo, R., Yang, M., Wang, M., Silk, P. J., Ryall, K., Roscoe, L. E., Cordes, D. B., Slawin, A. M. Z. & O'Hagan, D., 24 May 2019, In : Tetrahedron. 75, 21, p. 2917-2922

    Research output: Contribution to journalArticle

  4. Acetyl coenzyme A analogues as rationally designed inhibitors of citrate synthase

    Bello, D., Rubanu, M. G., Bandaranayaka, N., Götze, J. P., Bühl, M. & O'Hagan, D., 2 May 2019, In : ChemBioChem. 20, 9, p. 1174-1182

    Research output: Contribution to journalArticle

Related by journal

  1. Artificial intelligence in pharmaceutical research and development

    Mitchell, J. B. O., Jul 2018, In : Future Medicinal Chemistry. 10, 13, p. 1529-1531 3 p.

    Research output: Contribution to journalEditorial

  2. Informatics, machine learning and computational medicinal chemistry

    Mitchell, J. B., Mar 2011, In : Future Medicinal Chemistry. 3, 4, p. 451-467 17 p.

    Research output: Contribution to journalReview article

  3. Fluorinase: a tool for the synthesis of F-18-labeled sugars and nucleosides for PET

    Onega, M., Winkler, M. & O'Hagan, D., Aug 2009, In : Future Medicinal Chemistry. 1, 5, p. 865-873 9 p.

    Research output: Contribution to journalReview article

ID: 46700994